Related references
Note: Only part of the references are listed.The Emerging Role of miR-375 in Cancer
Jun-Wei Yan et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Selective Requirement of PI3K/PDK1 Signaling for Kras Oncogene-Driven Pancreatic Cell Plasticity and Cancer
Stefan Eser et al.
CANCER CELL (2013)
Single Copies of Mutant KRAS and Mutant PIK3CA Cooperate in Immortalized Human Epithelial Cells to Induce Tumor Formation
Grace M. Wang et al.
CANCER RESEARCH (2013)
Targeting microRNAs in Pancreatic Cancer: Microplayers in the Big Game
Sheema Khan et al.
CANCER RESEARCH (2013)
Loss of PTEN Expression Is Associated with Poor Prognosis in Patients with Intraductal Papillary Mucinous Neoplasms of the Pancreas
Dario Garcia-Carracedo et al.
CLINICAL CANCER RESEARCH (2013)
Roles for KRAS in Pancreatic Tumor Development and Progression
Marina Pasca di Magliano et al.
GASTROENTEROLOGY (2013)
Evolution and dynamics of pancreatic cancer progression
S. Yachida et al.
ONCOGENE (2013)
MicroRNA-375 targets the 3-phosphoinositide-dependent protein kinase-1 gene in pancreatic carcinoma
Shi-Duo Song et al.
ONCOLOGY LETTERS (2013)
PDK1 Signaling Toward PLK1-MYC Activation Confers Oncogenic Transformation, Tumor-Initiating Cell Activation, and Resistance to mTOR-Targeted Therapy
Jing Tan et al.
CANCER DISCOVERY (2013)
Computational Modeling of Pancreatic Cancer Reveals Kinetics of Metastasis Suggesting Optimum Treatment Strategies
Hiroshi Haeno et al.
CELL (2012)
Circulating MicroRNAs in Serum of Human K-ras Oncogene Transgenic Rats With Pancreatic Ductal Adenocarcinomas
Setsuko Yabushita et al.
PANCREAS (2012)
Down-Regulation of Yes Associated Protein 1 Expression Reduces Cell Proliferation and Clonogenicity of Pancreatic Cancer Cells
Caroline H. Diep et al.
PLOS ONE (2012)
K-RAS Mutant Pancreatic Tumors Show Higher Sensitivity to MEK than to PI3K Inhibition In Vivo
Irmgard Hofmann et al.
PLOS ONE (2012)
Targeting Phosphoinositide 3-Kinase Pathways in Pancreatic Cancer - from Molecular Signalling to Clinical Trials
Marco Falasca et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2011)
Activated KrasG12D is associated with invasion and metastasis of pancreatic cancer cells through inhibition of E-cadherin
S. Rachagani et al.
BRITISH JOURNAL OF CANCER (2011)
Receptor Tyrosine Kinases and TLR/IL1 Rs Unexpectedly Activate Myeloid Cell PI3Kγ, A Single Convergent Point Promoting Tumor Inflammation and Progression
Michael C. Schmid et al.
CANCER CELL (2011)
Tissue and Serum microRNAs in the KrasG12D Transgenic Animal Model and in Patients with Pancreatic Cancer
Joseph J. LaConti et al.
PLOS ONE (2011)
RAS oncogenes: weaving a tumorigenic web
Yuliya Pylayeva-Gupta et al.
NATURE REVIEWS CANCER (2011)
A novel inhibitor of the PI3K/Akt pathway based on the structure of inositol 1,3,4,5,6-pentakisphosphate
M. Falasca et al.
BRITISH JOURNAL OF CANCER (2010)
PTEN Loss Accelerates KrasG12D-Induced Pancreatic Cancer Development
Reginald Hill et al.
CANCER RESEARCH (2010)
Key Role of Phosphoinositide 3-Kinase Class IB in Pancreatic Cancer
Charlotte E. Edling et al.
CLINICAL CANCER RESEARCH (2010)
KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma
John P. Morris et al.
NATURE REVIEWS CANCER (2010)
MicroRNAs in Cancer
Yong Sun Lee et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)
Regulation of Pancreas Plasticity and Malignant Transformation by Akt Signaling
Lynda Elghazi et al.
GASTROENTEROLOGY (2009)
miR-375 targets 3'-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic β-cells
Abdelfattah El Ouaamari et al.
DIABETES (2008)
Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers
Jeffrey A. Engelman et al.
NATURE MEDICINE (2008)
Class IPI3K in oncogenic cellular transformation
L. Zhao et al.
ONCOGENE (2008)
PI3K pathway alterations in cancer: variations on a theme
T. L. Yuan et al.
ONCOGENE (2008)
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses
Sian Jones et al.
SCIENCE (2008)
The role of PKC and PDK1 in monocyte lineage specification by Ras
Lorna Pearn et al.
BLOOD (2007)
K-Ras promotes growth transformation and invasion of immortalized human pancreatic cells by Raf and phosphatidylinositol 3-kinase signaling
Paul M. Campbell et al.
CANCER RESEARCH (2007)
Prognostic significance of activated Akt expression in pancreatic ductal adenocarcinoma
S Yamamoto et al.
CLINICAL CANCER RESEARCH (2004)
Oncogenic K-ras drives cell cycle progression and phenotypic conversion of primary pancreatic duct epithelial cells
C Agbunag et al.
CANCER RESEARCH (2004)
The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-κB and c-Myc in pancreatic cancer cells
T Asano et al.
ONCOGENE (2004)
Predictive factors for pancreatic cancer in patients with chronic pancreatitis in association with K-ras gene mutation
M Arvanitakis et al.
ENDOSCOPY (2004)
Oncogenic mutations of PIK3CA in human cancers
Y Samuels et al.
CELL CYCLE (2004)
Incidence, mechanism and prognostic value of activated AKT in pancreas cancer
MG Schlieman et al.
BRITISH JOURNAL OF CANCER (2003)
Share Paper
